Who Gets To Sit At The Table in Pandemic Treaty Negotiations? Debate Opens Pandora’s Box of Vested Interests 20/07/2022 Nicoletta Dentico & Ashka Naik Should the corporate sector be allowed to engage in negotiations around the new binding instrument on pandemic prevention, preparedness and response that is being developed by World Health Organization member states? This week’s closed-door debate by WHO member states to decide who should get a seat around the table risks opening a Pandora’s box of […] Continue reading -> Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Tackles ‘Last Mile’ of Getting Vaccines into Arms 06/05/2022 Kerry Cullinan Now that COVAX has enough stock of COVID-19 vaccines, its focus is on vaccination uptake – including encouraging countries to combine campaigns against measles and polio with COVID-19, and even helping with “campaign-style” vaccination drives. This emerged at a media briefing on vaccine delivery called by the Access to COVID-19 Tools (ACT) Accelerator, of which […] Continue reading -> Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lack of COVID-19 Testing is Undermining Global Tracking – And Uptake of the New Antiviral Drugs 26/04/2022 Kerry Cullinan & Raisa Santos The precipitous drop in COVID-19 testing across the world since January has made it harder to track the evolution of variants, and is also undermining the potential of new antiviral drugs that have to be taken early to be effective. Testing was a major focus of Tuesday’s meeting of the Access to COVID Tools Accelerator […] Continue reading -> The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Dilemma of Vaccine ‘Charity’ vs Building Africa’s Production Capacity 25/04/2022 Kerry Cullinan CAPE TOWN – As the health sector celebrates World Immunisation Week, one of the most pressing related problems is Africa’s almost total dependence on imported vaccines – something that predates, but was highlighted by, the COVID-19 pandemic. But addressing this dependence will mean dismantling the ‘charity’ model that has underpinned many of Africa’s immunisation programmes […] Continue reading -> Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Latest Peer-Reviewed Study Underlines Benefits of Second COVID Booster for Older People 18/04/2022 Maayan Hoffman The latest study on the effectiveness of a second COVID-19 booster, published last week in the New England Journal of Medicine, has shown that within a period of two weeks to one month after receiving the jab, recipients’ infection rates dropped by one-half and severe cases and deaths by three-quarters. The study, conducted by Israel’s […] Continue reading -> Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Call to Save African Vaccine Producer Aspen as Countries Opt for Donations Not Orders 14/04/2022 Kerry Cullinan Aspen, the South African based pharmaceutical company licensed to produce the Johnson & Johnson COVID-19 vaccine, has not yet received a single order from the African continent and might close its COVID vaccine production line. This was disclosed by Dr John Nkengasong, director of the Africa Centre for Disease Control and Prevention, at a media […] Continue reading -> Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Second Anniversary of COVID-19 – ´Building Back Better´ Encounters New Challenges 11/03/2022 Raisa Santos & Elaine Ruth Fletcher Two years after the World Health Organization declared the novel coronavirus outbreak a global pandemic on 11 March 2022, the developed world’s long-time fixation on the SARS-CoV2 virus, which has killed 6 million people, has suddenly shifted away from health to the war in Ukraine and sharply rising geopolitical tensions. Meanwhile high-income countries have dropped […] Continue reading -> BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
BioNTech To Ship Modular mRNA Vaccine Facilities in Containers to African Countries to Jump-start Production 16/02/2022 Elaine Ruth Fletcher The German-based BioNTech, which co-developed with Pfizer an mRNA COVID vaccine, said on Wednesday that it will set up modular “turnkey” mRNA vaccine facilities to produce the vaccine in Rwanda and Senegal in 2022 – with a fill-and-finish collaboration in Ghana as well. South Africa, which is the new hub for the WHO-supported mRNA vaccine […] Continue reading -> US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US and Africa Plan to Harness PEPFAR Networks to Increase COVID Vaccine Uptake 15/02/2022 Kerry Cullinan CAPE TOWN – The US and Africa intend to use the well-established community networks supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) to improve the uptake of COVID-19 vaccines in Africa. The initaitive would build upon the infrastructure developed since PEPFAR entered as a major player on the African AIDS scene in 2003. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy